JEREMY STARR: Open Payments
NPI 1699876987 · NORTH LOGAN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$364 in 16 payments from 12 companies in 2025. Trend: 2023 $321 · 2024 $207 · 2025 $364
Food & beverage: $364
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $66 |
| Dexcom, Inc. | 2 | $51 |
| Supernus Pharmaceuticals, Inc. | 1 | $45 |
| Lilly USA, LLC | 2 | $34 |
| Organon LLC | 2 | $31 |
| SANOFI-AVENTIS U.S. LLC | 1 | $27 |
| PFIZER INC. | 1 | $22 |
| ACADIA Pharmaceuticals Inc | 1 | $20 |
| ABBVIE INC. | 1 | $20 |
| Exact Sciences Corporation | 1 | $20 |
Products named: CAPLYTA, Dexcom G6 Transmitter, Qelbree, MOUNJARO, NEXPLANON, TZIELD, NURTEC ODT, DAYBUE.
Industry payments across UT — which companies pay providers there.
